Rennova Health, Inc. (RNVA)

Rennova Health Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 3, 2026	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Last Close Price	0.00	0.00	0.00	0.01	131000.00	10.00

Financial Efficiency

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 3, 2026	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Debt / Equity Ratio	-0.32	-0.32	-0.52	-0.59	-0.45	-0.73
Debt / EBITDA Ratio	5.83	5.83	-	-	-	-
Debt / FCF Ratio	3.88	3.88	-	-	-	-
Net Debt / Equity Ratio	-0.32	-0.32	-0.50	-0.56	-0.45	-0.73
Net Debt / EBITDA Ratio	7.00	7.00	-15.39	-1.60	-1.35	-3.43
Net Debt / FCF Ratio	3.86	3.86	-57.61	-1.72	-1.27	-3.71
Asset Turnover	0.92	0.92	0.65	0.20	0.53	1.11
Inventory Turnover	34.37	34.37	25.87	14.58	22.24	27.65
Quick Ratio	0.09	0.09	0.09	0.09	0.03	0.05
Current Ratio	0.16	0.16	0.13	0.10	0.05	0.06
Return on Assets (ROA)	4.18%	4.18%	-4.41%	-40.05%	-78.54%	-66.81%
Return on Capital Employed (ROCE)	-6.10%	-6.10%	4.90%	38.20%	36.10%	22.50%

Yields

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 3, 2026	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Buyback Yield / Dilution	-228.51%	-228.51%	-1822047.62%	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2023

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 3, 2026

Data Sources Report a data error